Clinical trials

  • LERIGLITAZONE for Cerebral X-linked adrenoleukodystrophy (CALD)|Adrenoleukodystrophy
  • INFLUENZA VIRUS B/AUSTRIA/1359417/2021 - LIKE STRAIN; INFLUENZA VIRUS A/VICTORIA/4897/2022 (H1N1)PDM09 - LIKE STRAIN; INFLUENZA VIRUS A/THAILAND/8/2022 (H3N2)-LIKE STRAIN for Influenza
  • 2-(6-[18F]FLUORO-PYRIDIN-3-YL)-9H-DIPYRIDO[2,3-B:3',4'-D]PYRROLE for Neurodegenerative diseases
  • PEMBROLIZUMAB for Non-small cell lung cancer
  • TEMOZOLOMIDE for Locally advanced rectal cancer
  • MESENCHYMAL STROMAL CELLS, EX VIVO CULTURED for Traumatic brain injury
  • N-ETHYL-2-[4-[7-[[4-(ETHYLSULFONYLAMINO)CYCLOHEXYL]METHYL]-2,7-DIAZASPIRO[3.5]NONAN-2-YL]PYRIMIDIN-5-YL]OXY-5-FLUORO-N-PROPAN-2-YLBENZAMIDE for Relapsed or refractory acute leukemia
  • FOSTEMSAVIR for HIV-1 infection | Multi-drug resistant HIV-1
  • Levobupivacaine for Chronic postsurgical pain (inguinal)|Inguinal hernia
  • HYDROXYCARBAMIDE for Sickle Cell Disease
  • ZIMISLECEL for Type 1 diabetes mellitus | Impaired hypoglycemic awareness | Severe hypoglycemia
  • Levocarnitine; Glucose monohydrate; Xylitol for End-stage renal disease